Therapeutic Bed Market Analysis By Product (Clinical, Household, Accessories), By Type (Acute Care, Critical Care, Long-term) And Segment Forecasts To 2024

Published: Jun, 2014 | Pages: 84 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global Therapeutic Bed Market is expected to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base coupled with the rising cases of obesity, chronic conditions, and viral infections are expected to boost market growth over the forecast period.

As per the U.S. Bureau of Labor Statistics, the rank of home health aides and personal care aides is expected to increase to 13.0 million in 2020 (a 70.0% increase from 2010), thereby increasing the demand for home care. This growth is expected to increase the sale of household therapeutic beds and propel growth over the forecast period. Considering that the treatment costs at home are lower than other settings, many patients are now preferring home healthcare, thus, ultimately increasing the demand for therapeutic beds in these facilities.

Another macro factor promoting the Therapeutic Bed Market is the increase in the volume of healthcare settings across the globe. With the help of this grant, 17 new hospitals and the expansion of 137 hospitals and primary health centers are anticipated, thereby increasing the sale of therapeutic beds. Similarly, in Qatar, the number of hospital beds is expected to rise from 4,980 in 2013 to 5,725 in 2018. These expansions are expected to create new avenues for market players to capitalize on.

Further key findings from the study suggest:

The household bed segment is identified as the fastest growing. The growing penetration of home healthcare services for preventive care, post-operative care, and for long-term chronic therapies are expected to drive the growth over the forecast period.

Clinical beds have been further sub-segmented into regular, ICU, pediatric, birthing, bariatric, low air loss, and other beds. Bariatric beds are expected to gain the highest application in regions such as the U.S., Canada, the UK, and Germany due to the rising number of obese population.

North America is expected to dominate the overall market throughout the forecast period, owing to the presence of well-developed primary, secondary, tertiary care hospitals, the presence of a well-developed reimbursement network, government funding, and high public and private expenditure in the hospitals sector

Asia Pacific is anticipated to be the fastest growing region. The market is expected to grow at a CAGR of about 7.0% over the forecast period. The hospital to beds ratio is below the WHO standards in several Asia Pacific countries and the governments are investing significant resources to improve the healthcare infrastructure in this region.

Key players of the industry include Invacare Corporation, Hill-Rom, Inc., Stryker Corporation, ArjoHuntleigh, Gendron, Inc., Hard Manufacturing Co., Bakare, Medline Industries, Sunrise Medical, and GF Health Products, Inc. Most of these companies have been in the business for over a decade and are bringing in expertise and technological advancement that are expected to help them sustain over the forecast period.

In order to curb competition, major market players are working towards the acquisition of emerging entrants. For instance, in January 2015, Stryker Corporation acquired the assets of CHG hospital Beds, Inc., a privately held company to enhance the low height bed designs portfolio.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Therapeutic Bed Market- Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Therapeutic Beds Industry Outlook
3.1. Therapeutic Bed Market Segmentation
3.2. Therapeutic Bed Market Size and Growth Prospects
3.3. Therapeutic Bed Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Growing base of geriatric population base
3.3.1.2. Growing prevalence of chronic diseases
3.3.1.3. Growing demand for home healthcare
3.3.1.4. Technological advancements
3.3.1.5. Other drivers
3.3.2. Market Restraint Analysis
3.3.2.1. High price of products
3.4. Key Opportunities Prioritized
3.5. Industry Analysis - Porter's
3.6. Therapeutic Bed Market PESTEL Analysis, 2015
Chapter 4. Therapeutic Beds Product Outlook
4.1. Therapeutic Bed Market Share By Product, 2015 & 2024
4.2. Clinical Beds
4.2.1. Clinical Beds Market Estimates and Forecasts, 2014 - 2024
4.2.2. Regular Medical Beds
4.2.2.1. Regular Medical Beds Market Estimates and Forecasts, 2014 - 2024
4.2.3. ICU Beds
4.2.3.1. ICU Beds Market Estimates and Forecasts, 2014 - 2024
4.2.4. Pediatric Beds
4.2.4.1. Pediatric Beds Estimates and Forecasts, 2014 - 2024
4.2.5. Birthing Beds
4.2.5.1. Birthing Beds Market Estimates and Forecasts, 2014 - 2024
4.2.6. Bariatric Beds
4.2.6.1. Birthing Beds Market Estimates and Forecasts, 2014 - 2024
4.2.7. Low Air Loss Bed Systems
4.2.7.1. Low Air Loss Bed Systems Estimates and Forecasts, 2014 - 2024
4.2.8. Others
4.2.8.1. Others Estimates and Forecasts, 2014 - 2024
4.3. Household Beds
4.3.1. Household Beds Market Estimates and Forecasts, 2014 - 2024
4.4. Accessories
4.4.1. Accessories Market Estimates and Forecasts, 2014 - 2024
Chapter 5. Therapeutic Beds Type Outlook
5.1. Therapeutic Bed Market Share By Type, 2015 & 2024
5.2. Acute Care
5.2.1. Acute Care Based Therapeutic Bed Market Estimates and Forecasts, 2014 - 2024
5.3. Critical Care
5.3.1. Critical Care Based Therapeutic Bed Market Estimates and Forecasts, 2014 - 2024
5.4. Long-term
5.4.1. Long-term Based Therapeutic Bed Market Estimates and Forecasts, 2014 - 2024
Chapter 6. Therapeutic Beds Regional Outlook
6.1. Therapeutic Bed Market Share By Region, 2015 & 2024
6.2. North America
6.2.1. North America Market Estimates and Forecasts, by Product, 2014 - 2024 (USD Million)
6.2.1.1. U.S. Market Estimates and Forecasts
6.2.1.2. Canada Market Estimates and Forecasts
6.2.2. North America Market Estimates and Forecasts, by Type, 2014 - 2024 (USD Million)
6.2.2.1. U.S. Market Estimates and Forecasts
6.2.2.2. Canada Market Estimates and Forecasts
6.3. Europe
6.3.1. Europe Market Estimates and Forecasts, by Product, 2014 - 2024 (USD Million)
6.3.1.1. UK Market Estimates and Forecasts
6.3.1.2. Germany Market Estimates and Forecasts
6.3.2. Europe Market Estimates and Forecasts, by Type, 2014 - 2024 (USD Million)
6.3.2.1. UK Market Estimates and Forecasts
6.3.2.2. Germany Market Estimates and Forecasts
6.4. Asia Pacific
6.4.1. Asia Pacific Market Estimates and Forecasts, by Product, 2014 - 2024 (USD Million)
6.4.1.1. Japan Market Estimates and Forecasts
6.4.1.2. China Market Estimates and Forecasts
6.4.2. Asia Pacific Market Estimates and Forecasts, by Type, 2014 - 2024 (USD Million)
6.4.2.1. Japan Market Estimates and Forecasts
6.4.2.2. China Market Estimates and Forecasts
6.5. Latin America
6.5.1. Latin America Market Estimates and Forecasts, by Product, 2014 - 2024 (USD Million)
6.5.1.1. Mexico Estimates and Forecasts
6.5.1.2. Argentina Estimates and Forecasts
6.5.2. Latin America Market Estimates and Forecasts, by Type, 2014 - 2024 (USD Million)
6.5.2.1. Mexico Estimates and Forecasts
6.5.2.2. Argentina Estimates and Forecasts
6.6. MEA
6.6.1. MEA Market Estimates and Forecasts, by Product, 2014 - 2024 (USD Million)
6.6.1.1. South Africa Estimates and Forecasts
6.6.1.2. Saudi Arabia Estimates and Forecasts
6.6.2. MEA Market Estimates and Forecasts, by Type, 2014 - 2024 (USD Million)
6.6.2.1. South Africa Estimates and Forecasts
6.6.2.2. Saudi Arabia Estimates and Forecasts
Chapter 7. Competitive Landscape
7.1. ArjoHuntleigh
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Bakare
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Invacare Corporation
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Hill Rom, Inc.
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Stryker Corporation
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Gendron, Inc.
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Hard Manufacturing Co.
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. GF Health Products, Inc.
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Sunrise Medical
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. Medline Industries
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives

List of Tables


TABLE 1 Country share estimation
TABLE 2 Therapeutic beds- Industry Snapshot & Key Buying Criteria, 2014 - 2024
TABLE 3 Global Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 4 Global Therapeutic Bed Market, by type,2014 - 2024 (USD Million)
TABLE 5 Global Therapeutic Bed Market, by region, 2014 - 2024 (USD Million)
TABLE 6 Therapeutic beds- Key market driver analysis
TABLE 7 Therapeutic beds- Key market restraint analysis
TABLE 8 North America Therapeutic Bed Market, by region, 2014 - 2024 (USD Million)
TABLE 9 North America Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 10 North AmericaTherapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 11 U.S. Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 12 U.S. Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 13 Canada Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 14 Canada Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 15 Europe Therapeutic Bed Market, by region, 2014 - 2024 (USD Million)
TABLE 16 Europe Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 17 Europe Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 18 UK Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 19 UK Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 20 Germany Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 21 Germany Therapeutic Bed Market, by type,2014 - 2024 (USD Million)
TABLE 22 Asia Pacific Therapeutic Bed Market, by region, 2014 - 2024 (USD Million)
TABLE 23 Asia Pacific Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 24 Asia Pacific Therapeutic Bed Market, by type,2014 - 2024 (USD Million)
TABLE 25 Japan Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 26 Japan Therapeutic Bed Market, by type,2014 - 2024 (USD Million)
TABLE 27 China Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 28 China Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 29 Latin America Therapeutic Bed Market, by region, 2014 - 2024 (USD Million)
TABLE 30 Latin America Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 31 Latin America Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 32 Brazil Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 33 Brazil Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 34 Argentina Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 35 Argentina Therapeutic Bed Market, by type,2014 - 2024 (USD Million)
TABLE 36 MEA Therapeutic Bed Market, by region, 2014 - 2024 (USD Million)
TABLE 37 MEA Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 38 MEA Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 39 South Africa Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 40 South Africa Therapeutic Bed Market, by type, 2014 - 2024 (USD Million)
TABLE 41 Saudi Arabia Therapeutic Bed Market, by product, 2014 - 2024 (USD Million)
TABLE 42 Saudi Arabia Therapeutic Bed Market, by type,2014 - 2024 (USD Million)